I’m in Missouri, and I just saw a Kansas City Star story, “Brownback says health care law cost is far above official estimate.” Excerpt: “Sam Brownback and other Republican U.S. senators across the country are telling voters that the new health care law will cost $2.6 trillion — a price that wildly inflates the official [...]
Something doesn’t smell right about the announcement that the U.S. Preventive Services Task Force cancelled its November meeting – a meeting at which a new vote was to be taken on prostate cancer screening recommendations. I’ve been assured by some who are very close to the process that there’s nothing fishy – that it was [...]
In a New York Times column this week, David Leonhardt reflects on how “any deficit strategy needs to focus on Medicare.” Excerpt: “The treatment of prostate cancer offers a good example of the trouble with the current system. I devoted a column to prostate cancer last year, and the Health Affairs article — by Steven [...]
Joanne Kenen of the New America Foundation is one of the few journalists (so far) to write about “The National Survey of Medical Decisions…(and) a series of papers and editorials in the journal Medical Decision Making. It comes at a time when ‘patient-centered care’ is a new buzzword in U.S. medicine; ‘shared decision-making’ and development [...]
Here’s a story that has far more than Minnesota ramifications. But how do you reconcile that story – which explains that the governor, “who is considering a run for president, has made no secret of his opposition to federal health reform” and who “announced an executive order designed to keep “Obamacare” out of Minnesota” with [...]
Only so much to say about this story. It’s about Senator David Vitter of Louisana. He says that an FDA advisory committee’s vote to revoke the approval of Roche-Genentech’s Avastin for treating breast cancer is “essentially government rationing.” The WSJ reports: New studies presented to the panel showed more side effects among women being treated [...]
On the Forbes blog this week: “Dendreon shares are down today on the heels of news that the Centers for Medicare and Medicaid Services (CMS) will undergo a lengthy review of whether or not Provenge “is reasonable and necessary under sections 1862(a)(1)(A) and/or 1862(a)(1)(E) of the Social Security Act” and should be reimbursed by Medicare. [...]
The worst-kept secret in journalism circles recently was that the New York Times was planning an article critical of the Dartmouth Atlas. That article was published online last night. Among the main points in the article: • “The mistaken belief that the Dartmouth research proves that cheaper care is better care is widespread.” • “the [...]
US Senator David Vitter (R-LA) wrote to HHS Secretary Kathleen Sebelius last week requesting that she have the Agency for Healthcare Research and Quality remove from its website last Fall’s breast cancer screening recommendations from the US Preventive Services Task Force. Vitter writes: “The recommendations were ill-conceived from the start – developed via a process [...]
The AP reports that a group opposing the current health care reform legislation has “outraged” Pennsylvania Democratic Rep. Kathy Dahlkemper, who recently lost both parents to cancer. The ad reflects on the US Preventive Services Task Force’s breast cancer screening recommendations from last November. Among the distortions in the ad are its claims that the [...]